A Study of the TheraBionic P1 Device in Breast Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of the TheraBionic P1 Device in Breast Cancer — Stella

Home/Breast Cancer Stage I/

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer Stage I trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Karmanos Cancer Institute, Detroit, Michigan

Key details

Sponsor

Barbara Ann Karmanos Cancer Institute

Enrollment target

~24 participants

Started

October 2026

Primary completion

April 2027

Age range

22 Years and older

Sex

Female only

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.